Opioid Antagonists – Traumatic Brain Injury
Opioid Antagonists – Traumatic Brain Injury Ulrich Lanius Ph.D. & Galyn Forster M.A. Clinical Abstract Background: Traumatic brain injury (TBI) is a major global cause of morbidity and long‑term disability. Experimental and clinical observations suggest that opioid antagonists—including naloxone, naltrexone, and nalmefene—may mitigate secondary injury processes and enhance neurological recovery following TBI. Objective: To summarize […]
Warning – Fake Medications

What is LDN? Protect your health when buying medicines online. 1 in 10 people in the UK have bought fake medical products online in the last year Fake medicines and medical devices bought online can lead to serious negative health consequences. Buying from dodgy websites also increases the risk of being ripped off through credit […]
LDN and Pain Paper
Research Article – Journal of Pain Management and Therapy (2019) Volume 3, Issue 1 February 1st 2019 Treating chronic pain with low dose naltrexone and ultralow dose naltrexone: a review paper. Naltrexone is an opioid receptor antagonist with FDA approval for treating opioid addiction since 1984. While typical dose for treating opioid addiction with naltrexone […]